Bevacizumab Injection
Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb)
Fully humanized monoclonal antibody biosimilar as a broad-spectrum antitumor drug
Bevacizumab（Arketin）, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb), specifi_x005fcally binds to VEGF to prevent VEGF from binding to its receptor, thereby reducing neovascularization, inducing degeneration of existing blood vessels and inhibiting tumor growth. As a broad-spectrum anti-tumor agent, bevacizumab is a standard regimen recommended in treatment guidelines for various malig_x0002_nancies worldwide. Since entering the market, its efficacy and safety have been widely demonstrated in clinical practice.
Indications
Metastatic colorectal cancer; advanced, metastatic, or recurrent non-small cell lung cancer; recurrent glioblastoma; epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; and cervical cancer.
Recommended reading
How to choose a suitable bevacizumab biosimilar manufacturer?
Related products
-
-
Dual station factory test bench
Contact UsThe motor factory test bench, model ZY4800A-2, is a comprehensive test bench for production line general inspection and testing equipment.
-
Gel & Clot Activator Tube
Contact UsGel and clot activator tube is used for blood serum biochemistry, immunology and drug testing, etc.
-
321 Stainless Steel Tube
Contact UsGrade: 200series, 300series, 400series, etc
Standard: ASTM/DIN/GB/JIS/AISI
Surface: No.1/2B/BA/NO.4/6K/8K/HL(Hairline)/PVC
Payment: Term T/T; L/C; Western Union; Paypal
Delivery Time: 7-15 days upon receipt of the deposit
Package: Standard Export Packing or As Customers Requirement
Reviews
There are no reviews yet.